Target intelligence / Profile preview

RNA, U6 small nuclear 160, pseudogene (RNU6-160P)

Target
RNU6-160P
Molecular classification
Other (Pseudogene, non-coding RNA derived pseudogene)
01

Overview

RNU6-160P is a genomic pseudogene derived from the U6 small nuclear RNA (snRNA) family. U6 snRNA is an essential RNA component of the spliceosome, which catalyzes pre-mRNA splicing in the cell nucleus[1][4]. U6 snRNA itself is highly conserved and critical to cell viability, but pseudogenes such as RNU6-160P result from duplication or mutation events that render them non-functional[6]. These pseudogenes may contain sequence elements similar to the active U6 snRNA but lack genuine biological activity, often showing partial sequence homology and sometimes duplication or rearrangement[6]. Multiple U6 pseudogenes exist in the human genome, highlighting the evolutionary importance of the functional U6 snRNA gene[4][6]. RNU6-160P does not participate in splicing, is not transcribed in a regulated fashion, and has no established role in cellular biology, disease, or therapy.\n\nIn summary, RNU6-160P is a non-functional pseudogene and does not represent a valid, actionable molecular target for therapeutic intervention or drug discovery[6][4].

Other names
RNU6-160PU6 small nuclear RNA pseudogene 160U6-160PRNA, U6 small nuclear 160
02

Mechanism of action

None applicable for drugs, as RNU6-160P is not a target for drug action.

03

Biological functions

None known; pseudogenes do not have active biological functions. The functional counterpart, U6 snRNA, participates in mRNA splicing, but the pseudogene itself lacks such activity
04

Disease associations

None known; pseudogenes, including RNU6-160P, are not known to play a direct role in disease mechanisms. Rarely, pseudogenes may have regulatory roles, but this has not been established for RNU6-160P

Beyond the preview

Go deeper on RNA, U6 small nuclear 160, pseudogene (RNU6-160P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 160, pseudogene (RNU6-160P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call